Omeros Corp. (OMER)
13.21
-0.80
(-5.71%)
USD |
NASDAQ |
Nov 20, 16:00
13.22
0.00 (0.00%)
After-Hours: 20:00
Omeros EPS Diluted (Quarterly) : -0.7859 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.7859 |
| June 30, 2026 | 0.1476 |
| March 31, 2026 | 0.7795 |
| December 31, 2025 | 0.9771 |
| September 30, 2025 | -0.4666 |
| June 30, 2025 | -0.434 |
| March 31, 2025 | -0.5763 |
| December 31, 2024 | -0.5408 |
| September 30, 2024 | -0.5562 |
| June 30, 2024 | -0.9672 |
| March 31, 2024 | -0.6324 |
| December 31, 2023 | -0.1452 |
| September 30, 2023 | -0.6006 |
| June 30, 2023 | -0.5935 |
| March 31, 2023 | -0.5364 |
| December 31, 2022 | 2.051 |
| September 30, 2022 | -0.2783 |
| June 30, 2022 | -0.4918 |
| March 31, 2022 | -0.5263 |
| December 31, 2021 | -0.4001 |
| September 30, 2021 | -0.3632 |
| June 30, 2021 | -0.4584 |
| March 31, 2021 | -0.5666 |
| December 31, 2020 | -0.6045 |
| September 30, 2020 | -0.6605 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.6108 |
| March 31, 2020 | -0.5346 |
| December 31, 2019 | -0.5773 |
| September 30, 2019 | -0.3334 |
| June 30, 2019 | -0.2944 |
| March 31, 2019 | -0.4967 |
| December 31, 2018 | -0.4802 |
| September 30, 2018 | -0.8114 |
| June 30, 2018 | -0.6964 |
| March 31, 2018 | -0.6224 |
| December 31, 2017 | -0.3446 |
| September 30, 2017 | -0.1617 |
| June 30, 2017 | -0.3261 |
| March 31, 2017 | -0.3443 |
| December 31, 2016 | -0.45 |
| September 30, 2016 | -0.34 |
| June 30, 2016 | -0.32 |
| March 31, 2016 | -0.54 |
| December 31, 2015 | -0.52 |
| September 30, 2015 | -0.53 |
| June 30, 2015 | -0.44 |
| March 31, 2015 | -0.51 |
| December 31, 2014 | -0.61 |
| September 30, 2014 | -0.54 |
| June 30, 2014 | -0.53 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.221 |
| Aytu BioPharma, Inc. | -0.2008 |
| Daré Bioscience, Inc. | -0.1813 |
| Jaguar Health, Inc. | -9.226 |
| Structure Therapeutics, Inc. | -1.992 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -63.82M |
| Revenue (Quarterly) | 35.93M |
| Total Expenses (Quarterly) | 99.76M |
| Enterprise Value | 1.180B |
| Gross Profit Margin (Quarterly) | 97.26% |
| Profit Margin (Quarterly) | -177.6% |
| Earnings Yield | 8.47% |
| Normalized Earnings Yield | 14.28 |